About Bio-Rad Laboratories, Inc. (BIO)
Bio-Rad Laboratories, Inc. is a Medical Devices company operating in the Healthcare sector.
BIO trades on the US stock exchanges (NYSE/NASDAQ) and is classified as a large-cap stock .
Key Statistics
- Current Price
- $372.18
- Market Cap
- $9.95B
- 52-Week High
- $396.23
- 52-Week Low
- $236.73
- Sector
- Healthcare
- Industry
- Medical Devices
$1,000 Invested in Bio-Rad Laboratories, Inc. (BIO)
How much would $1,000 invested in BIO be worth today?
What would $1,000 invested in BIO 1 year ago be worth today?
A $1,000 investment in Bio-Rad Laboratories, Inc. (BIO) in 2025 would be worth $1,222 as of November 2026, representing a +22.2% total return.
What would $1,000 invested in BIO 3 years ago be worth today?
A $1,000 investment in Bio-Rad Laboratories, Inc. (BIO) in 2023 would be worth $1,277 as of November 2026, representing a +27.7% total return.
What would $1,000 invested in BIO 5 years ago be worth today?
A $1,000 investment in Bio-Rad Laboratories, Inc. (BIO) in 2021 would be worth $483 as of November 2026, representing a -51.7% total return.
What would $1,000 invested in BIO 10 years ago be worth today?
A $1,000 investment in Bio-Rad Laboratories, Inc. (BIO) in 2016 would be worth $2,282 as of November 2026, representing a +128.2% total return.
What would $1,000 invested in BIO at IPO be worth today?
A $1,000 investment in Bio-Rad Laboratories, Inc. (BIO) at IPO would be worth $146,165 as of November 2026, representing a +14516.5% total return.
Monthly Returns Heatmap
Over the past 46+ years (560 months), Bio-Rad Laboratories, Inc. (BIO) has averaged a monthly return of +1.43% with a median return of +0.84%. The stock had 307 positive months (55%) and 245 negative months (44%). The best month in BIO's history was September 1980 with a +46.4% return, while the worst was October 1987 at -39.9%. Historically, April tends to be the strongest month (averaging +4.1%), and September the weakest (-1.3%).
BIO's longest winning streak was 9 consecutive months of gains, while its longest losing streak was 6 consecutive months of losses. The best full year was 1994 with a cumulative return of +114.1%, and the worst was 1981 at -60.8%.
Annual Returns
Over 46 years of trading history, Bio-Rad Laboratories, Inc. (BIO) has delivered an average annual return of +17.59% with a median return of +11.39%. The compound annual growth rate (CAGR) is +11.08%. The stock posted gains in 29 years (63%) and losses in 17 years (37%).
BIO's best year was 1994 with a +177.50% gain, while the worst was 1981 at -51.25%. The longest streak of consecutive positive years was 5, and the longest losing streak was 2 years. BIO achieved double-digit gains (10%+) in 24 years. It suffered double-digit losses in 10 years.
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | +22.84% | $302.99 | $372.18 |
| 2025 | -7.77% | $328.51 | $302.99 |
| 2024 | +1.74% | $322.89 | $328.51 |
| 2023 | -23.21% | $420.49 | $322.89 |
| 2022 | -44.35% | $755.57 | $420.49 |
| 2021 | +29.61% | $582.94 | $755.57 |
| 2020 | +57.54% | $370.03 | $582.94 |
| 2019 | +59.34% | $232.22 | $370.03 |
| 2018 | -2.70% | $238.67 | $232.22 |
| 2017 | +30.94% | $182.28 | $238.67 |
| 2016 | +31.46% | $138.66 | $182.28 |
| 2015 | +15.01% | $120.56 | $138.66 |
| 2014 | -2.47% | $123.61 | $120.56 |
| 2013 | +17.67% | $105.05 | $123.61 |
| 2012 | +9.38% | $96.04 | $105.05 |
| 2011 | -7.52% | $103.85 | $96.04 |
| 2010 | +7.66% | $96.46 | $103.85 |
| 2009 | +28.08% | $75.31 | $96.46 |
| 2008 | -27.32% | $103.62 | $75.31 |
| 2007 | +25.57% | $82.52 | $103.62 |
| 2006 | +26.10% | $65.44 | $82.52 |
| 2005 | +14.07% | $57.37 | $65.44 |
| 2004 | -0.52% | $57.67 | $57.37 |
| 2003 | +49.02% | $38.70 | $57.67 |
| 2002 | +22.27% | $31.65 | $38.70 |
| 2001 | +99.06% | $15.90 | $31.65 |
| 2000 | +36.04% | $11.69 | $15.90 |
| 1999 | +11.31% | $10.50 | $11.69 |
| 1998 | -19.62% | $13.06 | $10.50 |
| 1997 | -12.92% | $15.00 | $13.06 |
| 1996 | +5.88% | $14.17 | $15.00 |
| 1995 | +53.15% | $9.25 | $14.17 |
| 1994 | +177.50% | $3.33 | $9.25 |
| 1993 | -41.61% | $5.71 | $3.33 |
| 1992 | -13.29% | $6.58 | $5.71 |
| 1991 | +6.76% | $6.17 | $6.58 |
| 1990 | +15.63% | $5.33 | $6.17 |
| 1989 | -5.88% | $5.67 | $5.33 |
| 1988 | +11.48% | $5.08 | $5.67 |
| 1987 | -11.59% | $5.75 | $5.08 |
| 1986 | +13.74% | $5.06 | $5.75 |
| 1985 | +137.39% | $2.13 | $5.06 |
| 1984 | -14.81% | $2.50 | $2.13 |
| 1983 | +87.50% | $1.33 | $2.50 |
| 1982 | -7.69% | $1.44 | $1.33 |
| 1981 | -51.25% | $2.96 | $1.44 |
Frequently Asked Questions: BIO
What sector is BIO in? ▼
BIO operates in the Healthcare sector, specifically in the Medical Devices industry. This sector includes pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare providers.
How has BIO performed historically? ▼
Over 46 years of trading history, BIO has posted gains in 29 years (63% of the time). The best year was 1994 with a +177.5% return. Past performance does not guarantee future results.
How can I invest in BIO? ▼
You can invest in BIO through any brokerage account that offers access to US stock exchanges. Popular options include commission-free brokers like Fidelity, Charles Schwab, or Robinhood (US), or international brokers like Interactive Brokers. You can buy individual shares or invest through ETFs that hold BIO.
Last updated: 11/1/2026